ONCO
Onconetix Inc
NASDAQ: ONCO · HEALTHCARE · BIOTECHNOLOGY
$0.64
-8.57% today
Updated 2026-05-01
Market cap
$514220.00
P/E ratio
—
P/S ratio
0.63x
EPS (TTM)
$-82.80
Dividend yield
—
52W range
$1 – $54
Volume
9.4M
Onconetix Inc (ONCO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-422.10%
ROE
-115.50%
ROA
-14.90%
Debt/equity
0.05x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-821915.00 | — | — | — |
| 2020 | $0.00 | $-1.60M | — | — | — |
| 2021 | $0.00 | $-3.42M | — | — | — |
| 2022 | $0.00 | $-13.42M | — | — | — |
| 2023 | $58465.00 | $-37.41M | -1,927.93% | -61,634.47% | -63,986.48% |
| 2024 | $2.52M | $-58.69M | 41.80% | -2,237.96% | -2,325.21% |
| 2025 | $815371.00 | $-14.03M | 77.62% | -778.16% | -1,720.98% |